Wednesday, February 10, 2010, 12:52PM AEST - The Australian Stockmarket closes in 3 hours and 13 minutes.
To create a watchlist or portfolio of shares, Register

Shire plc (SHPGY)

7:59AM AEST: 58.49 USD  Up 0.80 (1.39%)  
 MORE ON SHPGY 
Quotes
Charts
Technical Analysis
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
HeadlinesGet Headlines for:
Thu, Feb 4, 2010
Pfizer's Hedge Pays Off
at Motley Fool (Thu, Feb 4)
Wed, Feb 3, 2010
Shire to Present Important Study Findings for Gaucher Disease Treatment and GLD Development Program at the Lysosomal Disease Network (LDN) World Sympo
PRNewswire (Wed, Feb 3)
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
EDGAR Online (Wed, Feb 3)
Tue, Feb 2, 2010
VYVANSE(R) - new ADHD treatment option - now available in Canada
CNW Group (Tue, Feb 2)
Thu, Jan 21, 2010
Shire, Covidien Lead High-Flying Stocks
at TheStreet.com (Thu, Jan 21)
Biotech Stocks: Drug stocks diverge; Shire, Lexicon in spotlight
at MarketWatch (Thu, Jan 21)
For Health Care Reform, a New Prescription
at SmartMoney.com (Thu, Jan 21)
Wed, Jan 20, 2010
Brown Win Boosts Big Pharma
at Forbes.com (Wed, Jan 20)
Shire upped to overweight by J.P. Morgan
at MarketWatch (Wed, Jan 20)
SHIRE PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Wed, Jan 20)
Tue, Jan 19, 2010
Genzyme: Shire Chomping at the Bit
at Seeking Alpha (Tue, Jan 19)
Shire Plc upgraded by Jefferies & Co
Briefing.com (Tue, Jan 19)
Thu, Jan 14, 2010
Get Ready to Buy
at Motley Fool (Thu, Jan 14)
Wed, Jan 6, 2010
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
EDGAR Online (Wed, Jan 6)
Hospira Inks Deal with Genzyme
Zacks.com (Wed, Jan 6)
Fri, Jan 1, 2010
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
EDGAR Online (Fri, Jan 1)
Tue, Dec 29, 2009
Shire Seeks FDA Approval
Zacks.com (Tue, Dec 29)
Thu, Dec 24, 2009
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
EDGAR Online (Thu, Dec 24)
Wed, Dec 23, 2009
FDA to issue decision on Shire's Gaucher drug
at MarketWatch (Wed, Dec 23)
Shire applies for U.S. approval for Fabry drug
at MarketWatch (Wed, Dec 23)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News7 Indices